Christopher Dinsmore serves as Executive at Kronos Bio, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Dinsmore has executed 18 insider transactions totaling $883.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 4, 2024 involved selling 7,366 shares valued at $8.7K.
Christopher Dinsmore currently holds 260,969 shares of Kronos Bio, Inc. (KRON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Dinsmore has been a net seller of KRON stock. They have purchased $99.8K and sold $783.5K worth of shares.
Christopher Dinsmore's most recent insider trade was on Jan 4, 2024, when they sold 7,366 shares at $1.18 per share.
Get notified when new Form 4 filings are submitted
| $1.31 |
| Discretionary |
| Jul 6, 2023 | KRON | $11.6K | Sale | 6,634 | $1.75 | Discretionary |
| Feb 24, 2023 | KRON | $10.9K | Sale | 6,291 | $1.74 | Discretionary |
| Feb 15, 2023 | KRON | $0 | Award | 119,882 | $N/A | Discretionary |
| Dec 12, 2022 | KRON | $16.5K | Sale | 9,138 | $1.81 | Discretionary |
| Jul 25, 2022 | KRON | $0 | Award | 43,550 | $N/A | Discretionary |
| Feb 15, 2022 | KRON | $0 | Award | 43,550 | $N/A | Discretionary |
| Dec 13, 2021 | KRON | $138.6K | Sale | 11,212 | $12.36 | Discretionary |
| Dec 13, 2021 | KRON | $2.2K | Sale | 174 | $12.82 | Discretionary |
| Oct 4, 2021 | KRON | $30.0K | Option Exercise | 9,189 | $3.27 | Discretionary |
| Oct 4, 2021 | KRON | $191.2K | Sale | 9,189 | $20.81 | Discretionary |
| Sep 7, 2021 | KRON | $30.0K | Option Exercise | 9,189 | $3.27 | Discretionary |
| Sep 7, 2021 | KRON | $201.3K | Sale | 9,189 | $21.91 | Discretionary |
| Aug 2, 2021 | KRON | $30.0K | Option Exercise | 9,189 | $3.27 | Discretionary |
| Aug 2, 2021 | KRON | $189.2K | Sale | 9,189 | $20.59 | Discretionary |
| Dec 9, 2020 | KRON | $0 | Award | 91,110 | $N/A | Discretionary |
| Oct 14, 2020 | KRON | $99.8K | Purchase | 5,250 | $19.00 | Discretionary |